Holen Sie sich die Stockscreener-App
2.74
1.56%
-0.03
Schlusskurs vom Vortag:
$2.77
Offen:
$2.88
24-Stunden-Volumen:
256.36K
Relative Volume:
3.91
Marktkapitalisierung:
$7.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.56M
KGV:
-0.2817
EPS:
-9.7281
Netto-Cashflow:
$-12.24M
1W Leistung:
+0.25%
1M Leistung:
-3.65%
6M Leistung:
-60.91%
1J Leistung:
-67.92%
1-Tages-Spanne:
$2.675
$3.1499
1-Wochen-Bereich:
$2.45
$3.22
52-Wochen-Spanne:
$1.76
$19.63
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
2.74 | 7.37M | 0 | -13.56M | -12.24M | -9.7281 |
VRTX
Vertex Pharmaceuticals Inc
|
433.69 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.13 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.05 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.03 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Heatwurx (NASDAQ:PCSA) versus Aquestive Therapeutics (NASDAQ:AQST) Critical Review - Defense World
Insider Buying: James Neal Acquires Shares of Processa Pharmaceu - GuruFocus
Processa Pharmaceuticals Insiders Increase Stock Holdings - Intellectia AI
Director Neal James R adds Processa (PCSA) shares in open trade - Stock Titan
Insider Buying: Russell Skibsted Acquires Shares of Processa Pharmaceuticals Inc (PCSA) - GuruFocus
Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 - Investing.com UK
Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 By Investing.com - za.investing.com
Processa Pharma chief business officer Lin buys $4063 in PCSA By Investing.com - Investing.com Canada
Young David, processa pharma pres, buys PCSA shares worth $4588 - Investing.com
Processa Pharma director Pannu buys $5,252 in PCSA stock - Investing.com UK
Processa Pharma director Pannu buys $5,252 in PCSA stock By Investing.com - Investing.com Australia
Young David, processa pharma pres, buys PCSA shares worth $4588 By Investing.com - Investing.com Canada
Ng George K, Processa Pharma CEO, buys PCSA stock worth $5414 - Investing.com Canada
Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 By Investing.com - Investing.com South Africa
Processa Pharmaceuticals (PCSA) R&D head adds 1,810 shares in open-market buy - Stock Titan
Processa Pharmaceuticals (NASDAQ: PCSA) CFO buys 2,324 company shares - Stock Titan
Director Geraldine Pannu buys 2,072 Processa (PCSA) shares in market - Stock Titan
[Form 4] Processa Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 - Investing.com
Processa Pharmaceuticals (PCSA) officer adds 1,603-share open-market buy - Stock Titan
Processa Pharmaceuticals (PCSA) CAO buys 1,854 shares in open trade - Stock Titan
Processa (NASDAQ: PCSA) CDO buys 2,107 shares in open-market trade - Stock Titan
Director adds 2,269 Processa (PCSA) shares at $2.535 each - Stock Titan
Processa Pharmaceuticals, Inc.Common Stock (NQ: PCSA - The Chronicle-Journal
Weekly Earnings: Should I hold or sell Processa Pharmaceuticals Inc now2026 Volume & Verified Chart Pattern Trade Signals - baoquankhu1.vn
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Aug PreEarnings: What is Processa Pharmaceuticals Incs valuation compared to sector2026 Trading Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
PCSA PE Ratio & Valuation, Is PCSA Overvalued - Intellectia AI
Trading Recap: Does Processa Pharmaceuticals Inc have a sustainable dividend2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Earnings Recap: Does Processa Pharmaceuticals Inc have strong fundamentalsRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in Processa Pharmaceuticals Inc (PCSA) - Stock Titan
Processa Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings - marketscreener.com
Aug Macro: Can Processa Pharmaceuticals Inc maintain sales growthMarket Growth Summary & Daily Price Action Insights - baoquankhu1.vn
Processa Pharmaceuticals Inc: Fundamental Analysis and Financial Ratings - marketscreener.com
Analyst Calls: What are the risks of holding Processa Pharmaceuticals Inc2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Processa Pharmaceuticals 2025 Annual Report: Next Generation Cancer Therapies, Regulatory Strategy, Pipeline, and Intellectual Property Overview - Minichart
Processa Pharmaceuticals 2025 10-K: $0 revenue, $(10.36) EPS on $(13.56)M net loss - TradingView
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[10-K] Processa Pharmaceuticals, I... - Stock Titan
Processa Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Processa Pharmaceuticals Inc expected to post a loss of $1.50 a shareEarnings Preview - tradingview.com
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Gardner News
Growth Recap: Whats Processa Pharmaceuticals Incs historical return2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
EV Market: Can Processa Pharmaceuticals Inc maintain sales growthPortfolio Performance Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Aug Summary: Does Processa Pharmaceuticals Inc have a sustainable dividendWeekly Market Report & Entry Point Strategy Guides - baoquankhu1.vn
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Can Processa Pharmaceuticals Inc maintain sales growthJuly 2025 Trends & Weekly Top Performers Watchlists - baoquankhu1.vn
Processa Pharmaceuticals Stock Quote, Share Price, News and Analysis - Longbridge
Aug Setups: Will Vishay Intertechnology Inc benefit from current market trends2025 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Death Cross: What is Processa Pharmaceuticals Incs valuation compared to sectorRate Hike & Weekly Top Performers Watchlists - baoquankhu1.vn
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Processa Pharmaceuticals Inc-Aktie (PCSA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Young David | Pres. Research & Development |
Mar 31 '26 |
Buy |
2.54 |
1,810 |
4,588 |
10,562 |
| SKIBSTED RUSSELL | Chief Financial Officer |
Mar 31 '26 |
Buy |
2.54 |
2,324 |
5,891 |
2,324 |
| Pannu Geraldine | Director |
Mar 31 '26 |
Buy |
2.54 |
2,072 |
5,253 |
2,188 |
| Ng George K | Chief Executive Officer |
Mar 31 '26 |
Buy |
2.54 |
2,136 |
5,415 |
3,649 |
| Lin Patrick | Chief Business - Strategy Off |
Mar 31 '26 |
Buy |
2.54 |
1,603 |
4,064 |
3,356 |
| Guy Wendy | Chief Administrative Officer |
Mar 31 '26 |
Buy |
2.54 |
1,854 |
4,700 |
3,110 |
| Bigora Sian | Chief Development Officer |
Mar 31 '26 |
Buy |
2.54 |
2,107 |
5,341 |
3,711 |
| Baluch Khoso | Director |
Mar 31 '26 |
Buy |
2.54 |
2,269 |
5,752 |
2,325 |
| Young David | Pres. Research & Development |
Jan 01 '26 |
Option Exercise |
0.00 |
49 |
0 |
8,752 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 01 '26 |
Option Exercise |
0.00 |
193 |
0 |
1,753 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):